Independent news reporting and media coverage of meditation retreats, safety discussions, and related incidents for readers researching public information.
The Dark Side of Meditation: Mental Health Risks
Meditation is widely promoted as a tool for stress reduction and emotional wellbeing, yet emerging research suggests that some individuals may experience serious adverse effects during or after practice. This article explores the growing body of evidence surrounding meditation-related psychological and cognitive disturbances, particularly in intensive retreat settings.
Researchers have documented a wide range of reported symptoms, including anxiety, depression, dissociation, depersonalisation, paranoia, fear, trauma re-experiencing and psychotic or delusional states. Some cases have involved severe outcomes such as hospitalisation and suicidality, with symptoms lasting months or even years. Studies suggest that prolonged retreats involving extended meditation sessions, silence, sleep disruption and dietary restrictions may increase the likelihood of adverse experiences.
The article also highlights concerns about the lack of monitoring within mindfulness research. Fewer than 20 per cent of mindfulness-based studies actively assess negative outcomes, raising questions about underreporting and the broader understanding of meditation-related harm. Researchers argue that more comprehensive studies are needed to identify who may be most vulnerable and which forms of practice carry greater risk.
Healthcare professionals are encouraged to take a more individualised approach when recommending meditation practices. Factors such as trauma history, psychiatric vulnerability and current mental health symptoms may influence how a person responds to meditation. The article suggests that physicians and mental health practitioners should ensure patients are properly informed about both the potential benefits and possible risks associated with contemplative practices.
The discussion ultimately calls for a more balanced and evidence-based conversation around meditation — one that recognises that, while many people may find meditation helpful, it is not universally safe or appropriate in every context.
Researchers have documented a wide range of reported symptoms, including anxiety, depression, dissociation, depersonalisation, paranoia, fear, trauma re-experiencing and psychotic or delusional states. Some cases have involved severe outcomes such as hospitalisation and suicidality, with symptoms lasting months or even years. Studies suggest that prolonged retreats involving extended meditation sessions, silence, sleep disruption and dietary restrictions may increase the likelihood of adverse experiences.
The article also highlights concerns about the lack of monitoring within mindfulness research. Fewer than 20 per cent of mindfulness-based studies actively assess negative outcomes, raising questions about underreporting and the broader understanding of meditation-related harm. Researchers argue that more comprehensive studies are needed to identify who may be most vulnerable and which forms of practice carry greater risk.
Healthcare professionals are encouraged to take a more individualised approach when recommending meditation practices. Factors such as trauma history, psychiatric vulnerability and current mental health symptoms may influence how a person responds to meditation. The article suggests that physicians and mental health practitioners should ensure patients are properly informed about both the potential benefits and possible risks associated with contemplative practices.
The discussion ultimately calls for a more balanced and evidence-based conversation around meditation — one that recognises that, while many people may find meditation helpful, it is not universally safe or appropriate in every context.
One particularly striking detail appears in the fact section at the end of the article. It references a 1992 study by Shapiro, one of the few prospective studies specifically designed to investigate adverse meditation experiences. The study found that 63 per cent of participants attending an intensive Vipassana retreat reported at least one negative effect. Of those participants, 7.4 per cent experienced symptoms severe enough to stop meditating altogether, while one individual required hospitalisation after developing psychosis.